- Home
- ETON vs USCB Comparison
ETON vs USCB Comparison
Compare ETON & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- USCB
- Stock Information
- Founded
- ETON 2017
- USCB 2002
- Country
- ETON United States
- USCB United States
- Employees
- ETON N/A
- USCB N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- USCB Major Banks
- Sector
- ETON Health Care
- USCB Finance
- Exchange
- ETON Nasdaq
- USCB Nasdaq
- Market Cap
- ETON 388.3M
- USCB 316.4M
- IPO Year
- ETON 2018
- USCB 2021
- Fundamental
- Price
- ETON $17.68
- USCB $17.14
- Analyst Decision
- ETON Strong Buy
- USCB Strong Buy
- Analyst Count
- ETON 3
- USCB 3
- Target Price
- ETON $29.67
- USCB $22.00
- AVG Volume (30 Days)
- ETON 206.2K
- USCB 19.4K
- Earning Date
- ETON 11-11-2025
- USCB 10-30-2025
- Dividend Yield
- ETON N/A
- USCB 2.29%
- EPS Growth
- ETON N/A
- USCB 67.08
- EPS
- ETON N/A
- USCB 1.47
- Revenue
- ETON $58,181,000.00
- USCB $88,094,000.00
- Revenue This Year
- ETON $105.25
- USCB $25.60
- Revenue Next Year
- ETON $40.84
- USCB $5.04
- P/E Ratio
- ETON N/A
- USCB $11.88
- Revenue Growth
- ETON 85.40
- USCB 32.06
- 52 Week Low
- ETON $5.35
- USCB $13.90
- 52 Week High
- ETON $21.48
- USCB $21.86
- Technical
- Relative Strength Index (RSI)
- ETON 59.16
- USCB 48.65
- Support Level
- ETON $17.24
- USCB $17.16
- Resistance Level
- ETON $18.52
- USCB $17.45
- Average True Range (ATR)
- ETON 0.66
- USCB 0.46
- MACD
- ETON -0.07
- USCB -0.03
- Stochastic Oscillator
- ETON 54.10
- USCB 24.07
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.